Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:award |
Harvard President’s Challenge
MassChallenge winner |
| gptkbp:collaboratedWith |
gptkb:Tufts_University
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
vaccine delivery
sustained-release therapeutics |
| gptkbp:foundedIn |
2011
|
| gptkbp:founder |
gptkb:Thomas_Davison
gptkb:Patrick_Ho Katharina Maisel Michael Schrader |
| gptkbp:fundedBy |
gptkb:National_Institutes_of_Health
gptkb:Bill_&_Melinda_Gates_Foundation gptkb:BARDA |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaxess Technologies
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
MIMIX sustained-release patch
|
| gptkbp:technology |
silk-derived biomaterials
|
| gptkbp:website |
https://www.vaxess.com/
|
| gptkbp:bfsParent |
gptkb:Profectus_BioSciences
|
| gptkbp:bfsLayer |
7
|